(AGX) Argan - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US04010E1091
Stock: Power, Industrial, Telecom
Total Rating 56
Risk 90
Buy Signal 0.38
| Risk 5d forecast | |
|---|---|
| Volatility | 75.1% |
| Relative Tail Risk | -11.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.18 |
| Alpha | 218.97 |
| Character TTM | |
|---|---|
| Beta | 1.384 |
| Beta Downside | 1.251 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.75% |
| CAGR/Max DD | 2.92 |
EPS (Earnings per Share)
Revenue
Description: AGX Argan March 04, 2026
Argan, Inc. (AGX) operates in the power generation market, providing engineering, procurement, and construction (EPC) services. The companys business model focuses on large-scale energy projects, including alternative energy facilities like biomass, wind, battery storage, and solar. The power generation sector is capital-intensive, requiring specialized expertise in project management and execution.
AGXs Power Industry Services segment designs, builds, and commissions these projects for independent power producers, utilities, and equipment suppliers. Its Industrial Construction Services segment supports new plant construction and maintenance for industrial facilities. The company also has a Telecommunications Infrastructure Services segment, which installs underground and aerial cabling for communication and power networks, primarily serving government and utility clients in the mid-Atlantic US. This segment addresses the growing demand for robust digital infrastructure.
For more detailed financial analysis, ValueRay offers comprehensive data.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 119.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.27 > 0.02 and ΔFCF/TA 8.49 > 1.0 |
| NWC/Revenue: 41.23% < 20% (prev 34.85%; Δ 6.39% < -1%) |
| CFO/TA 0.27 > 3% & CFO 287.0m > Net Income 119.9m |
| Net Debt (-303.7m) to EBITDA (128.9m): -2.36 < 3 |
| Current Ratio: 1.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (14.2m) vs 12m ago 0.88% < -2% |
| Gross Margin: 19.20% > 18% (prev 0.14%; Δ 1906 % > 0.5%) |
| Asset Turnover: 100.6% > 50% (prev 104.9%; Δ -4.30% > 0%) |
| Interest Coverage Ratio: -1.81 > 6 (EBITDA TTM 128.9m / Interest Expense TTM -51.1m) |
Altman Z'' 4.78
| A: 0.36 (Total Current Assets 997.2m - Total Current Liabilities 619.9m) / Total Assets 1.05b |
| B: 0.35 (Retained Earnings 364.0m / Total Assets 1.05b) |
| C: 0.10 (EBIT TTM 92.6m / Avg Total Assets 909.9m) |
| D: 0.58 (Book Value of Equity 366.2m / Total Liabilities 631.2m) |
| Altman-Z'' Score: 4.78 = AA |
Beneish M -3.50
| DSRI: 0.96 (Receivables 213.4m/195.2m, Revenue 915.0m/806.3m) |
| GMI: 0.75 (GM 19.20% / 14.39%) |
| AQI: 0.75 (AQ_t 0.03 / AQ_t-1 0.04) |
| SGI: 1.13 (Revenue 915.0m / 806.3m) |
| TATA: -0.16 (NI 119.9m - CFO 287.0m) / TA 1.05b) |
| Beneish M-Score: -3.50 (Cap -4..+1) = AA |
What is the price of AGX shares?
As of March 04, 2026, the stock is trading at USD 438.93 with a total of 328,461 shares traded.
Over the past week, the price has changed by -1.94%, over one month by +14.98%, over three months by +25.18% and over the past year by +263.78%.
Over the past week, the price has changed by -1.94%, over one month by +14.98%, over three months by +25.18% and over the past year by +263.78%.
Is AGX a buy, sell or hold?
Argan has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy AGX.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AGX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 361 | -17.8% |
| Analysts Target Price | 361 | -17.8% |
AGX Fundamental Data Overview February 28, 2026
P/E Trailing = 53.1763
P/S = 6.8611
P/B = 14.9583
Revenue TTM = 915.0m USD
EBIT TTM = 92.6m USD
EBITDA TTM = 128.9m USD
Long Term Debt = 2.63m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 2.63m USD (from shortTermDebt, last quarter)
Debt = 2.63m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -303.7m USD (from netDebt column, last quarter)
Enterprise Value = 5.97b USD (6.28b + Debt 2.63m - CCE 306.3m)
Interest Coverage Ratio = -1.81 (Ebit TTM 92.6m / Interest Expense TTM -51.1m)
EV/FCF = 21.11x (Enterprise Value 5.97b / FCF TTM 283.0m)
FCF Yield = 4.74% (FCF TTM 283.0m / Enterprise Value 5.97b)
FCF Margin = 30.93% (FCF TTM 283.0m / Revenue TTM 915.0m)
Net Margin = 13.11% (Net Income TTM 119.9m / Revenue TTM 915.0m)
Gross Margin = 19.20% ((Revenue TTM 915.0m - Cost of Revenue TTM 739.3m) / Revenue TTM)
Gross Margin QoQ = 18.69% (prev 18.62%)
Tobins Q-Ratio = 5.69 (Enterprise Value 5.97b / Total Assets 1.05b)
Interest Expense / Debt = 23.95% (Interest Expense 629.0k / Debt 2.63m)
Taxrate = 22.57% (8.96m / 39.7m)
NOPAT = 71.7m (EBIT 92.6m * (1 - 22.57%))
Current Ratio = 1.61 (Total Current Assets 997.2m / Total Current Liabilities 619.9m)
Debt / Equity = 0.01 (Debt 2.63m / totalStockholderEquity, last quarter 419.7m)
Debt / EBITDA = -2.36 (Net Debt -303.7m / EBITDA 128.9m)
Debt / FCF = -1.07 (Net Debt -303.7m / FCF TTM 283.0m)
Total Stockholder Equity = 382.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 13.18% (Net Income 119.9m / Total Assets 1.05b)
RoE = 31.38% (Net Income TTM 119.9m / Total Stockholder Equity 382.2m)
RoCE = 24.07% (EBIT 92.6m / Capital Employed (Equity 382.2m + L.T.Debt 2.63m))
RoIC = 18.77% (NOPAT 71.7m / Invested Capital 382.2m)
WACC = 11.02% (E(6.28b)/V(6.28b) * Re(11.02%) + D(2.63m)/V(6.28b) * Rd(23.95%) * (1-Tc(0.23)))
Discount Rate = 11.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.18%
[DCF] Terminal Value 67.10% ; FCFF base≈226.5m ; Y1≈218.2m ; Y5≈214.3m
[DCF] Fair Price = 194.8 (EV 2.40b - Net Debt -303.7m = Equity 2.70b / Shares 13.9m; r=11.02% [WACC]; 5y FCF grow -4.94% → 2.90% )
EPS Correlation: 51.45 | EPS CAGR: -39.21% | SUE: -4.0 | # QB: 0
Revenue Correlation: 90.68 | Revenue CAGR: 20.30% | SUE: -0.72 | # QB: 0
EPS next Quarter (2026-04-30): EPS=1.82 | Chg7d=-0.325 | Chg30d=-0.100 | Revisions Net=-1 | Analysts=2
EPS next Year (2027-01-31): EPS=9.55 | Chg7d=+0.267 | Chg30d=+1.053 | Revisions Net=+3 | Growth EPS=+14.2% | Growth Revenue=+28.1%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.1% (Discount Rate 11.0% - Earnings Yield 1.9%)
[Growth] Growth Spread = +19.6% (Analyst 28.8% - Implied 9.1%)
P/S = 6.8611
P/B = 14.9583
Revenue TTM = 915.0m USD
EBIT TTM = 92.6m USD
EBITDA TTM = 128.9m USD
Long Term Debt = 2.63m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 2.63m USD (from shortTermDebt, last quarter)
Debt = 2.63m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -303.7m USD (from netDebt column, last quarter)
Enterprise Value = 5.97b USD (6.28b + Debt 2.63m - CCE 306.3m)
Interest Coverage Ratio = -1.81 (Ebit TTM 92.6m / Interest Expense TTM -51.1m)
EV/FCF = 21.11x (Enterprise Value 5.97b / FCF TTM 283.0m)
FCF Yield = 4.74% (FCF TTM 283.0m / Enterprise Value 5.97b)
FCF Margin = 30.93% (FCF TTM 283.0m / Revenue TTM 915.0m)
Net Margin = 13.11% (Net Income TTM 119.9m / Revenue TTM 915.0m)
Gross Margin = 19.20% ((Revenue TTM 915.0m - Cost of Revenue TTM 739.3m) / Revenue TTM)
Gross Margin QoQ = 18.69% (prev 18.62%)
Tobins Q-Ratio = 5.69 (Enterprise Value 5.97b / Total Assets 1.05b)
Interest Expense / Debt = 23.95% (Interest Expense 629.0k / Debt 2.63m)
Taxrate = 22.57% (8.96m / 39.7m)
NOPAT = 71.7m (EBIT 92.6m * (1 - 22.57%))
Current Ratio = 1.61 (Total Current Assets 997.2m / Total Current Liabilities 619.9m)
Debt / Equity = 0.01 (Debt 2.63m / totalStockholderEquity, last quarter 419.7m)
Debt / EBITDA = -2.36 (Net Debt -303.7m / EBITDA 128.9m)
Debt / FCF = -1.07 (Net Debt -303.7m / FCF TTM 283.0m)
Total Stockholder Equity = 382.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 13.18% (Net Income 119.9m / Total Assets 1.05b)
RoE = 31.38% (Net Income TTM 119.9m / Total Stockholder Equity 382.2m)
RoCE = 24.07% (EBIT 92.6m / Capital Employed (Equity 382.2m + L.T.Debt 2.63m))
RoIC = 18.77% (NOPAT 71.7m / Invested Capital 382.2m)
WACC = 11.02% (E(6.28b)/V(6.28b) * Re(11.02%) + D(2.63m)/V(6.28b) * Rd(23.95%) * (1-Tc(0.23)))
Discount Rate = 11.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.18%
[DCF] Terminal Value 67.10% ; FCFF base≈226.5m ; Y1≈218.2m ; Y5≈214.3m
[DCF] Fair Price = 194.8 (EV 2.40b - Net Debt -303.7m = Equity 2.70b / Shares 13.9m; r=11.02% [WACC]; 5y FCF grow -4.94% → 2.90% )
EPS Correlation: 51.45 | EPS CAGR: -39.21% | SUE: -4.0 | # QB: 0
Revenue Correlation: 90.68 | Revenue CAGR: 20.30% | SUE: -0.72 | # QB: 0
EPS next Quarter (2026-04-30): EPS=1.82 | Chg7d=-0.325 | Chg30d=-0.100 | Revisions Net=-1 | Analysts=2
EPS next Year (2027-01-31): EPS=9.55 | Chg7d=+0.267 | Chg30d=+1.053 | Revisions Net=+3 | Growth EPS=+14.2% | Growth Revenue=+28.1%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.1% (Discount Rate 11.0% - Earnings Yield 1.9%)
[Growth] Growth Spread = +19.6% (Analyst 28.8% - Implied 9.1%)